Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists
- PMID: 12760982
- DOI: 10.1213/01.ANE.0000062523.67426.0B
Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists
Comment in
-
Perioperative pulmonary embolism.Anesth Analg. 2003 Dec;97(6):1855. doi: 10.1213/01.ANE.0000077677.55641.EB. Anesth Analg. 2003. PMID: 14633578 No abstract available.
References
-
- Remolina C, Khan AU, Santiago TV, Edelman NH. Positional hypoxemia in unilateral lung disease. N Engl J Med 1981; 304: 523–5.
-
- Riedel B. The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery. Int Anesthesiol Clin 1999; 37: 55–79.
-
- Wanstall JC, Jeffery TK. Recognition and management of pulmonary hypertension. Drugs 1998; 56: 989–1007.
-
- Loscalzo J. Endothelial dysfunction in pulmonary hypertension. N Engl J Med 1992; 327: 117–9.
-
- Marczin N, Ryan US, Catravas JD. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ Res 1992; 70: 326–40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
